NEW HAVEN, Conn., May 13, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that 2025 employee stock options granted to certain members of Precipio’s management team vested last week because the Company’s Common Stock price increased by more than 400% since the options were granted. As proposed by the Company’s Compensation Committee in late 2024, rather than the standard 4-year time-based vesting period, management was offered and agreed to a market-based ...